Transcription of PRODUCT MONOGRAPH INCLUDING PATIENT …
{{id}} {{{paragraph}}}
ShingrixNovember 22, 2021 shingrix , Herpes Zoster vaccinePage 1 of 36 PRODUCT MONOGRAPHINCLUDING PATIENT MEDICATION INFORMATIONSHINGRIXH erpes Zoster vaccine (non-live recombinant, AS01 Badjuvanted)Suspension for injection, 50 mcg Varicella Zoster Virus (VZV) glycoprotein E (gE), Intramuscular InjectionActive Immunizing AgentGlaxoSmithKline RoadMississauga, OntarioL5N 6L4 Date of Initial Authorization:October13, 2017 Date of Revision:November 24, 2021 Submission Control Number: 246933 2021 GSK group of companies or its licensorTrademarks are owned by or licensed to theGSK group of companiesShingrixNovember 22, 2021 shingrix , Herpes Zoster vaccinePage 2 of 36 RECENTMAJOR LABEL CHANGESS ectionDate1 INDICATIONS11/20214 DOSAGE AND ADMINISTRATION, Recommended Dose andDose Adjustment11/20217 WARNINGSAND PRECAUTIONS11/2021 TABLE OF CONTENTSS ections orsubsectio
PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION SHINGRIX Herpes Zoster vaccine (non-live recombinant, AS01B adjuvanted) Suspension for injection, 50 mcg Varicella Zoster Virus (VZV) glycoprotein E (gE), Intramuscular Injection Active Immunizing Agent GlaxoSmithKline Inc. 7333Mississauga Road Mississauga, Ontario L5N 6L4
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}